Our previous results show that L-4F could inhibit pancreatic cancer progression, mostly by its anti-inflammatory effect, such as reduce the secretion of IL-6 in tumor tissue (Peng et al., 2017), While IL-6 could increase the infiltration of MDSCs in tumor tissue (Oh et al., 2013). Here, IL6 is linked to pancreatic neoplasm.